P2.17-21 Efficacy of Concurrent Carboplatin-Paclitaxel Chemoradiotherapy With 66 Gy for Elderly Patients With Stage III Non-Small Cell Lung Cancer

Journal of Thoracic Oncology- United States

doi 10.1016/j.jtho.2018.08.1547

Full Text

Abstract

Available in

Categories

Respiratory Medicine

Date

October 1, 2018

Authors

Publisher

Elsevier BV

Related search

P2.17-05 Consolidation Chemotherapy in Patients With Locally Advanced Non-Small Cell Lung Cancer After Concurrent Chemoradiotherapy

Journal of Thoracic Oncology

Respiratory Medicine

English

Neoadjuvant Chemoradiotherapy for Stage III Non-Small Cell Lung Cancer

Frontiers in Oncology

Cancer Research

English

Preoperative Concurrent Chemoradiotherapy for Stage IIIA Non-Small Cell Lung Cancer

Acta Oncologica

Nuclear Medicine

English

Concurrent Chemoradiation in Elderly Patients With Limited-Stage Small Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

P2.12-09 Efficacy and Safety of Carboplatin and Paclitaxel for Patients Preexisting Interstitial Lung Disease With Small Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

Safety of Adjuvant Chemotherapy With Carboplatin and Weekly Paclitaxel for Pathological Stage IB-IIIB Non-Small Cell Lung Cancer

Japanese Journal of Lung Cancer

Respiratory Medicine

English

Association of Chemoradiotherapy With Outcomes Among Patients With Stage I to II vs Stage III Small Cell Lung Cancer

Cancer Research

English

P2.17-07 Concurrent Chemoradiotherapy (ConCRT) Using Cisplatin-Vinorelbine in Locally Advanced (LA) Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology

Respiratory Medicine

English

Phase II Study of Consolidation Amrubicin After Concurrent Chemoradiotherapy in Patients With Limited-Stage Small-Cell Lung Cancer

Molecular Biology

English